Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05112432 · ClinicalTrials.gov registry record · NA
EPI-MINN: Targeting Cognition and Motivation
A NA study of Psychosis, sponsored by University of Minnesota.
- Active
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 3
- Study locations
NCT05112432 is a NA study of Psychosis that is active but no longer recruiting, run by University of Minnesota. The registered enrollment target is 400 participants, above the 167-participant average among 35 other Psychosis trials with a reported enrollment target (140% higher). The trial reports 3 study locations across 1 state.
The verdict
NCT05112432, a NA study of Psychosis, is active but no longer recruiting, sponsored by University of Minnesota.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to perform a practice-based research project designed to assess whether cognition and motivated behavior in early psychosis can be addressed as key treatment goals within real-world settings by using a 12-week mobile intervention program. Participants who are enrolled in a chart review study of measurement-based care will be recruited to participate in this study. In the measurement-based care study, participants are enrolled in coordinated specialty care programs for early psychosis that provide comprehensive clinical services such as psychotherapy, medication management, psychoeducation, work or education support, and measurement-based care. Participants will complete a set of well-defined measures every 6 months that assess symptoms, functioning, cognition and motivation as standard of care. The current study will utilize the data acquired in the measurement-based care study. The aim of this study is to investigate a well-defined 12-week mobile intervention program specifically designed to target cognitive functioning and motivated behavior for individuals with early psychosis. The investigators will test for differences in the clinical trajectories over 18 months in those who receive the intervention vs. those who do not. This study will be conducted jointly with a sister protocol under a separate NCT listing. This iteration will be conducted locally within the EPI-MINN Network, while the other project will be conducted on a national scale.
Conditions Studied
Interventions
- DEVICE Cognitive and Social Cognitive Training
- BEHAVIORAL Personalized Real-Time Intervention for Motivational Enhancement (PRIME) App
- OTHER Early Psychosis Coordinated Specialty Care
Study Locations (3)
Minnesota
- Human Development Center - Duluth
- Hennepin Healthcare - Minneapolis
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2021-08-12 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05112432
The ClinicalTrials.gov registry entry for NCT05112432 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 167-participant average among 35 other Psychosis trials with a reported enrollment target (140% higher). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Psychosis appearing as the primary indexed condition, and to 3 interventions - of which Cognitive and Social Cognitive Training is the first listed.
NCT05112432 reports 3 study locations spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05112432 about?
NCT05112432 is a clinical study titled "EPI-MINN: Targeting Cognition and Motivation". The purpose of this study is to perform a practice-based research project designed to assess whether cognition and motivated behavior in early psychosis can be addressed as key treatment goals within real-world settings by using a 12-week mobile intervention program. Participants who are enrolled in...
What is the current status of trial NCT05112432?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2021-08-12. Estimated completion is 2026-07-31.
What conditions does trial NCT05112432 study?
This clinical trial studies the following conditions: Psychosis.
What interventions are being tested in trial NCT05112432?
The interventions under investigation include: Cognitive and Social Cognitive Training (DEVICE), Personalized Real-Time Intervention for Motivational Enhancement (PRIME) App (BEHAVIORAL), Early Psychosis Coordinated Specialty Care (OTHER).
Who is sponsoring clinical trial NCT05112432?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05112432 being conducted?
This trial has 3 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Psychosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults
RECRUITING · NA
-
Determining the Role of Social Reward Learning in Social Anhedonia
RECRUITING · NA
-
Cerebellar Modulation of Cognition in Psychosis
RECRUITING · NA
-
Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia
RECRUITING · NA
-
Acute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient Care
RECRUITING · NA
-
Targeting Emotion Dysregulation to Reduce Suicide in People With Psychosis
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.